Cytoskeleton proteins can be altered as a part of the aging process [84, 85] and the associations between age and altered levels/phosphorylation of cytoskeletal proteins may therefore reflect an impact of aging in AML. The gene discussed is DNM2; the disease is acute myeloid leukemia.